Company intelligence / Profile preview

Amphibian

Lexington, Kentucky, United Statesamphibiaweb.org ↗

Ownership: Private
Development stage: Other

Overview

Amphibian BioTech was a specialized U.S.-based biotechnology company focused on breeding and supplying laboratory-raised frogs at all life stages as animal models to support basic biological and medical research as well as educational programs. The company's main customers were universities and laboratories requiring standardized amphibians—especially Xenopus species—for experiments in genetics, embryology, physiology, toxicology, pharmacology, and related fields. There is no evidence that the company develops drugs or diagnostics itself nor that it has been acquired or gone public.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Amphibian.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amphibian.

Explore the full profile